Status:
COMPLETED
A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic Blockade
Lead Sponsor:
Pfizer
Conditions:
Patients With Pace Makers But no Evidence of Ischemic Heart Disease
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
Brief Summary
To assess the effects of GTN on QT and QTc in subjects with And without atrial pacing. This will be done with and without autonomic blockade at two different pacing rates. Moxifloxacin effect on QT an...
Eligibility Criteria
Inclusion
- Patients with pace-makers but otherwise normal ventricular function
Exclusion
- Nitrates, beta blockers
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
June 1 2006
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00174512
Start Date
March 1 2005
End Date
June 1 2006
Last Update
November 8 2006
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Bruxelles (Brussels), Belgium
2
Pfizer Investigational Site
Glasgow, Scotland, United Kingdom
3
Pfizer Investigational Site
Leicester, United Kingdom
4
Pfizer Investigational Site
Liverpool, United Kingdom